Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia (Q36600934)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 September 2006

Language	Label	Description	Also known as
English	Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia	scientific article published on 14 September 2006

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia (English)

1 reference

Europe PubMed Central

15 August 2017

0 references

1 reference

based on heuristic

inferred from title

Andreas Hochhaus

3

object named as

Hochhaus A

1 reference

Europe PubMed Central

15 August 2017

author name string

Branford S

1

1 reference

Europe PubMed Central

15 August 2017

Cross NC

2

1 reference

Europe PubMed Central

15 August 2017

Radich J

4

1 reference

Europe PubMed Central

15 August 2017

Saglio G

5

1 reference

Europe PubMed Central

15 August 2017

Kaeda J

6

1 reference

Europe PubMed Central

15 August 2017

Goldman J

7

1 reference

Europe PubMed Central

15 August 2017

Hughes T

8

1 reference

Europe PubMed Central

15 August 2017

publication date

14 September 2006

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

20

1 reference

Europe PubMed Central

15 August 2017

1925-1930

1 reference

Europe PubMed Central

15 August 2017

11

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404388

0 references

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Quantitative real-time RT-PCR--a perspective.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Properties of the reverse transcription reaction in mRNA quantification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Comparison of reverse transcriptases in gene expression analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Molecular monitoring of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Standardized determination of real-time PCR efficiency from a single reaction set-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Validation of a quantitative method for real time PCR kinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

21 January 2018

Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative RT-PCR: limits and accuracy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative reverse transcriptase-PCR amplification of cytokine mRNA in liver biopsy specimens using a non-competitive method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404388

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404388

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36600934&oldid=1640235052"